Primerdesign and sister companies Microgen Bioproducts and Lab21 Healthcare, as part of the Novacyt Group, are excited to be exhibiting at the World’s largest medical laboratory exhibition, MEDLAB. Successfully running for the past 17 years, the exhibition serves to develop the value of laboratory medicine by shaping the future of healthcare. Hosted in Dubai from February 4th-7th the event will play host to more than 670 exhibitors from 46+ countries, and almost 20,000 attendees.
You can find us at the Novacyt stand – Za’abeel Hall 1, Booth Z1.B58. On the stand you can find:
- Phil Sefton – Group Commercial Director, Novacyt Group
- Sagar Vengurlekar – Head of Sales – International Markets, Primerdesign
- Simon Cook – Sales Director – EMEA & North America, Microgen Bioproducts
- Steve Birch – Director of Sales – Europe & Africa, Lab 21 Healthcare
Successfully operating in the MENA region for the past 17 years, MEDLAB is a truly respected annual industry event. Delegates will be able to participate in the congress and workshops to learn what new innovations are leading the medical lab industry. From artificial intelligence in the lab to cytogenetics and IVF. Committed to supporting the education of all faculty and medical lab professionals, MEDLAB also offers 11 CME-accredited conference tracks. Focusing on the core lab and specialist lab units, this year’s congress is led by a strong scientific committee, ensuring that current issues and innovation are at the centre of all programmes.
At the exhibition, Primerdesign, Microgen Bioproducts and Lab21 Healthcare will showcase their range of instruments and consumables in the real-time PCR market as well as their high-quality microbiology diagnostic products for laboratories.
CE-IVD marked molecular kits
Primerdesign will be promoting our new CE-IVD marked molecular kits; the genesig® Real-Time PCR BK virus (BKV) Kit (CE) and genesig® Real-Time PCR Epstein-Barr Virus (EBV) Kit (CE). These clinical products follow the launch of a Zika assay in the second half of 2017 and are the first of an expanding menu of molecular diagnostic tests for monitoring post-transplantation and immunosuppressed patients.
The new molecular kits have been developed to provide quantitative detection of viral DNA extracted from blood plasma and urine (BKV kit), or blood plasma and whole blood (EBV kit) from immunocompromised patients. Quantification standards in the kits are calibrated against the First World Health Organization International Standards for Virus Nucleic Acid Amplification Techniques (NIBSC code 14/212), producing strong levels of sensitivity and specificity performance as well as reproducibility.
PathFlow™ Rapid Tests
Microgen Bioproducts will be showcasing their range of new PathFlow™ products. A complete detection system, with no additional reagents required, the Pathflow products offer a simple to use, two-step process, providing results within five to ten minutes. The product works on multiple sample types and comes with an in-built procedural control, as well as both positive and negative control materials.
Learn more about the new PathFlow™ Mononucleosis product – a qualitative, lateral flow immunoassay for the detection of IM heterophile antibodies in whole blood, serum or plasma.
MEDLAB is a one-stop-shop for generating viable leads and doing business within the region. An invaluable platform that leverages its success from 15 years as part of Arab Health, coupled with great success as a standalone event. Visit their website now to get your free delegate pass and to learn more. If you would like to arrange a meeting with us in advance or learn more about any of our products, please get in touch – firstname.lastname@example.org.